Login / Signup

Non-vitamin K antagonist oral anticoagulants versus warfarin in AF patients ≥ 85 years.

Chuan-Tsai TsaiJo-Nan LiaoSu-Jung ChenYu-Ru JiangTzeng-Ji ChenTze Fan Chao
Published in: European journal of clinical investigation (2021)
For the efficacy, NOACs were associated with a comparable or lower risk of ischaemic stroke compared to warfarin. For adverse events, NOACs were associated with a lower risk of all-cause mortality and composite adverse events. In the elderly AF population, NOACs could be a more favourable choice for stroke prevention.
Keyphrases